Search | IOVS | ARVO Journals

View

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Changes in Etiologies of Uveitis in Japan

Keiko Fujii; Yoshihiko Usui; Kinya Tsubota; Akihiko Umazume; Ryosuke Mitsuhashi; Takeshi Kezuka; junichi sakai; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4162. doi:

ARVO Annual Meeting Abstract July 2018

Genetic analysis of IgG4-related ophthalmic disease using next-generation sequencing

Marina Ogawa; Yoshihiko Usui; Naoyuki Yamakawa; Kazuhiko Umazume; Kinya Tsubota; Rei Nemoto; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4324. doi:

ARVO Annual Meeting Abstract July 2018

Clinical features of primary vitreoretinal lymphomas with lesions involving organs other than central nervous system

Makoto Imazeki; Yoshihiko Usui; Kinya Tsubota; Kazuhiko Umazume; Rei Nemoto; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5582. doi:

ARVO Annual Meeting Abstract July 2018

Analysis of clinical features of primary vitreoretinal lymphoma followed for over 5 years

Kinya Tsubota; Yoshihiko Usui; Kazuhiko Umazume; Rei Nemoto; Motoko Shibata; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5583. doi:

ARVO Annual Meeting Abstract June 2017

Genetic alterations in IgG4-related ophthalmic disease identified using next-generation sequencing

Marina Ogawa; Yoshihiko Usui; Naoyuki Yamakawa; Kazuhiko Umazume; Kinya Tsubota; Rei Nemoto; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1792. doi:

ARVO Annual Meeting Abstract June 2017

Analysis of IL-10 in the intraocular fluids of patients with infectious uveitis

Ryosuke Matsushima; Yoshihiko Usui; Takeshi Kezuka; Kinya Tsubota; Akihiko Umazume; Naoyuki Yamakawa; Yoshihiro Wakabayashi; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2180. doi:

ARVO Annual Meeting Abstract September 2016

An effective and robust murine lens-induced myopia model evaluated with micro-CT imaging

Toshihide Kurihara; Xiaoyan Jiang; Kinya Tsubota; Kiwako Mori; Yukihiro Miwa; Yusaku Katada; Maki Miyauchi; Hidemasa Torii; Kazuo Tsubota

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5746. doi:

ARVO Annual Meeting Abstract June 2015

Identification and Quantification of the Murine Visual Cortex Activity by Functional MRI

Kinya Tsubota; Yuji Komaki; Norio Takata; Tetsu Yoshida; Kenji F Tanaka; Hideyuki Okano; Hiroshi Goto; Kazuo Tsubota; Toshihide Kurihara

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3373. doi:

ARVO Annual Meeting Abstract June 2015

Prominent arginine-proline metabolic pathway perturbations characterize human proliferative diabetic retinopathy and the oxygen-induced-retinopathy mouse model

Liliana P Paris; Caroline H. Johnson; Edith Aguilar; Daniel Feitelberg; Yoshihiko Usui; Kinya Tsubota; Shunichiro Ueda; Yoshihiro Wakabayashi; Gary Siuzdak; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5203. doi:

ARVO Annual Meeting Abstract April 2014

Identification of a metabolite that can prevent features associated with proliferative diabetic retinopathy

Liliana P Paris; Caroline H Johnson; Peter D Westenskow; Yoshihiko Usui; Edith Aguilar; Daniel Feitelberg; Kinya Tsubota; Shunichiro Ueda; Gary Siuzdak; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4926. doi:

ARVO Annual Meeting Abstract June 2013

Significance of measuring immune mediators for differentiating malignant from benign pigmented intraocular tumors

Yoshihiko Usui; Shunichiro Ueda; Yoko Okunuki; Kinya Tsubota; Kazuki Tajima; Takeshi Kezuka; Yoshihiro Wakabayashi; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):169. doi:

ARVO Annual Meeting Abstract June 2013

Effectiveness of prophylactic intravitreal bevacizumab injection in preventing complications after vitrectomy for proliferative diabetic retinopathy

Kinya Tsubota; Yoshihiro Wakabayashi; Shunichiro Ueda; Yoshihiko Usui; Jun Suzuki; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):198. doi:

Advertisement